Label at a glance#

ProductGeri-kot

Active ingredientSENNOSIDES

Label structure8 sections

Indications and uses

relieves occasional constipation (irregularity) generally produces bowel movement in 6 to 12 hours

Dosage and administration

• do not exceed 8 tablets in 24 hours Age Starting Dose Maximum Dose adults and children 12 years of age and older 2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor 4 tablets in the morning and 4 tablets at bedtime children under 12 years ask a doctor

Storage and handling

each tablet contains: calcium 25 mg Tamper Evident: Do not use if imprinted seal under cap is missing or broken store at room temperature

Label contents#

Full prescribing information#

Active ingredient (in each tablet)

OTC - ACTIVE INGREDIENT SECTION

Sennosides 8.6 mg

Purpose

OTC - PURPOSE SECTION

Laxative

Uses

INDICATIONS & USAGE SECTION

relieves occasional constipation (irregularity)

generally produces bowel movement in 6 to 12 hours

Warnings

WARNINGS SECTION

Do not use

for more than 1 week unless directed by a doctor.

Ask a doctor before use if you

have abdominal pain, nausea or vomiting
have noticed a sudden change in bowel habits that lasts over 2 weeks

Stop use and ask a doctor if

you have no bowel movement within 12 hours
you have rectal bleeding

These could be signs of a serious condition.

If pregnant or breast-feeding,

ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

• do not exceed 8 tablets in 24 hours

Age	Starting Dose	Maximum Dose
adults and children 12 years of age and older	2 tablets once a day preferably at bedtime; increase as needed, or as directed by a doctor	4 tablets in the morning and 4 tablets at bedtime
children under 12 years	ask a doctor

Other information

STORAGE AND HANDLING SECTION

each tablet contains: calcium 25 mg
Tamper Evident: Do not use if imprinted seal under cap is missing or broken
store at room temperature

Inactive ingredients

INACTIVE INGREDIENT SECTION

cellulose, croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium silicate, magnesium stearate, mineral oil, PEG.

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GERICARE
NDC 57896-450-01
Geri-kot
Standardized Senna Concentrate
COMPARE TO ACTIVE INGREDIENT
IN SENOKOT TABLETS
Natural Vegetable Laxative
100 Tablets
8.6 mg Each

420

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
57896-450-01	EA - Each	57896-450	429a0cc9-118a-43de-ad3e-e364aa8c17cd	1	2019-02-13

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 11 matching rows.

Geri-kot
Standardized Senna Concentrate
CELLULOSE, MICROCRYSTALLINE
CROSCARMELLOSE SODIUM
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS
MAGNESIUM SILICATE
MAGNESIUM STEARATE
MINERAL OIL
POLYETHYLENE GLYCOL, UNSPECIFIED
HYPROMELLOSES
SENNOSIDES

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
57896-450	57896-450-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
CROSCARMELLOSE SODIUM	M28OL1HH48	IACT
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS	L11K75P92J	IACT
MAGNESIUM SILICATE	9B9691B2N9	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
MINERAL OIL	T5L8T28FGP	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
HYPROMELLOSES	3NXW29V3WO	IACT
SENNOSIDES	3FYP5M0IJX	ACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b6721434-cc3f-cf76-e053-2a95a90a6c1f			616bfb9f-e492-f10e-e053-2a91aa0a54ad	2020-12-14	Warnings	Exact identifier spl set id: 616bfb9f-e492-f10e-e053-2a91aa0a54ad

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.